Mainz Biomed to unveil breakthrough early cancer detection study results at DDW 2024

  • Post author:
  • Post category:uncategorized

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, will present  an analysis from  its eAArly DETECT study at Digestive Disease Week (DDW) 2024 in Washington D.C. from May 18th to May 21st. DDW is recognized as a premier forum for the latest advancements in gastroenterology, hepatology, endoscopy, and gastrointestinal surgery.